Archives: April 2024
Four Stages of PAD and What They Mean
Peripheral artery disease affects an ever-growing number of patients in the United States and around the world. However, PAD remains a relatively less known concern among patients, and our medical system still needs to catch up with screening for this disease. To fully understand PAD, it’s best to compare it to coronary artery disease; imagine the plaque build-up in the arteries of the limbs – the legs and the arms. As with any artery, plaque can build up on the walls of the peripheral arteries and occlude the vessel, slowing down blood flow. To this end, PAD is often an indicator of future coronary artery disease.
Wegovy Approved for Heart Disease
What This Means for Your Health
On March 8, 2024, the U.S. Food and Drug Administration (FDA) approved Wegovy for use in patients with cardiovascular disease.1 Wegovy is an injectable medication that has recently gained attention for aiding weight loss and has also been proven to help with obesity. The FDA’s approval of Wegovy for use by patients with heart disease was confirmation that data shows a significant reduction in the risk for cardiovascular events such as heart attack and stroke.